ALYSSA BAEZ: Open Payments
NPI 1093445678 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$631 in 21 payments from 10 companies in 2025. Trend: 2023 $359 · 2024 $648 · 2025 $631
Food & beverage: $631
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $150 |
| Amgen Inc. | 2 | $146 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $77 |
| AstraZeneca Pharmaceuticals LP | 3 | $62 |
| ABIOMED | 1 | $26 |
| SCPHARMACEUTICALS INC. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| CVRx, Inc. | 1 | $19 |
Products named: LifeVest, REPATHA, LEQVIO, ELIQUIS, FARXIGA, CAMZYOS, FUROSCIX, Kerendia.
Industry payments across FL — which companies pay providers there.
